Genetic comparison of seizure control by norepinephrine and neuropeptide Y.
Epilepsy is a disease of neuronal hyperexcitability, and pharmacological and genetic studies have identified norepinephrine (NE) and neuropeptide Y (NPY) as important endogenous regulators of neuronal excitability. Both transmitters signal through G-protein-coupled receptors, are expressed either together or separately, and are abundant in brain regions implicated in seizure generation. NPY knock-out (NPY KO) and dopamine beta-hydroxylase knock-out (DBH KO) mice that lack NE are susceptible to seizures, and agonists of NE and NPY receptors protect against seizures. To examine the relative contributions of NE and NPY to neuronal excitability, we tested Dbh;Npy double knock-out (DKO) mice for seizure sensitivity. In general, DBH KO mice were much more seizure-sensitive than NPY KO mice and had normal NPY expression, demonstrating that an NPY deficiency did not contribute to the DBH KO seizure phenotype. DKO mice were only slightly more sensitive than DBH KO mice to seizures induced by kainic acid, pentylenetetrazole, or flurothyl, although DKO mice were uniquely prone to handling-induced seizures. NPY contributed to the seizure phenotype of DKO mice at high doses of convulsant agents and advanced stages of seizures. These data suggest that NE is a more potent endogenous anticonvulsant than NPY, and that NPY has the greatest contribution under conditions of extreme neuronal excitability.
Weinshenker
D
D
Departments of Howard Hughes Medical Institute, Biochemistry, Clinical Center, University of Washington, Seattle, Washington 98195, USA.
Szot
P
P
Miller
N S
NS
Rust
N C
NC
Hohmann
J G
JG
Pyati
U
U
White
S S
SS
Palmiter
R D
RD
D000818:Animals; D004299:Dopamine beta-Hydroxylase / Q000172:deficiency / Q000235:genetics; D005080:Exercise Test; D005481:Flurothyl; D020022:Genetic Predisposition to Disease; D006234:Handling, Psychological; D017403:In Situ Hybridization; D007608:Kainic Acid; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009478:Neuropeptide Y / Q000172:deficiency / Q000378:metabolism* / Q000494:pharmacology; D009638:Norepinephrine / Q000172:deficiency / Q000378:metabolism* / Q000494:pharmacology; D010433:Pentylenetetrazole; D010641:Phenotype; D012640:Seizures / Q000139:chemically induced / Q000503:physiopathology* / Q000517:prevention & control
D009478:Neuropeptide Y; D005481:Flurothyl; D004299:Dopamine beta-Hydroxylase; D007608:Kainic Acid; D010433:Pentylenetetrazole; D009638:Norepinephrine